HIGHLIGHTS
- who: Xuezhong Shi and collaborators from the Ben-Gurion University of the Negev, Guizhou Medical University, China have published the article: Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma, in the Journal: (JOURNAL)
- what: This study shows that scRNA-seq technology is a powerful tool for exploring tumor heterogeneity and different cell subpopulations, which is important for identifying potential therapeutic targets . The authors performed scRNAseq analysis to explore T-cell marker genes in LUSC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.